Anti-inflammatory tripeptide
A short peptide fragment (lysine-proline-valine) studied for anti-inflammatory effects, including in the gut.
Pre-clinical and early research interest in inflammation; robust human evidence is lacking.
Unregulated supply with unknown quality and no established human safety profile.
Not ARTG-approved. Online supply is not a lawful pathway for human use.
No lawful consumer supply. Not registered for human use.
This entry is general information about KPV, not a recommendation to use it. We don’t provide dosing, protocols or sourcing. Speak to a registered practitioner.
This is general education, not medical advice. Peptides.au does not sell, supply, recommend or promote any product or clinic. Always speak with a registered Australian health practitioner before making any health decision.